Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, has signed a Supply Agreement with a US-based company offering laboratory testing services, specialising in gut health for improved health outcomes.
Omega didn’t say which US company is in question, but it said that the agreement covers its microarray-based food intolerance product FoodPrint, is for an initial term of three years and is automatically renewable on the mutual agreement of both parties.
Omega pointed out that this agreement will enable it to increase traction in the US for FoodPrint which provides laboratories with a high throughput food sensitivity testing solution. Omega expects a modest contribution from this arrangement in the current financial year.
Andrew Shepherd, Chief Executive Officer of Omega, commented: “We are pleased to have signed this agreement that enables us to broaden our food intolerance product offering in the important US market. We are excited by the prospects for this relationship and believe the capabilities of our chosen partner will enable us to deliver better health outcomes for patients.”